← All organizations

Aduro BioTech

For profitWebsite ↗

Also known as: Aduro Biotech, Inc. | Hanlee P. Ji, MD

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 30, 2019

Timeline

2000s

Jan 1, 2000
Aduro BioTech— Founded

Drugs by trial phase (28 distinct, 16 trials)

Phase 2 (17 own, 0 via acquisition)

Phase 1 (11 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT03937141Lead sponsorPhase 2Jun 30, 2019
NCT03945318Lead sponsorPhase 1Apr 8, 2019
NCT03674502Lead sponsorPhase 1Oct 1, 2018
NCT03376477CollaboratorPhase 2Jul 10, 2018
NCT03340883Lead sponsorPhase 1/Phase 2Nov 15, 2017
NCT03190265CollaboratorPhase 2Oct 1, 2017
NCT03175172Lead sponsorPhase 2Jun 1, 2017
NCT03122548Lead sponsorPhase 2Jun 1, 2017
NCT03189030Lead sponsorPhase 1May 2, 2017
NCT03189030CollaboratorPhase 1May 2, 2017
NCT02675439Lead sponsorPhase 1Mar 1, 2016
NCT02575807Lead sponsorPhase 1/Phase 2Jan 1, 2016
NCT02243371CollaboratorPhase 2Dec 1, 2014
NCT02004262Lead sponsorPhase 2Jan 1, 2014
NCT01967758CollaboratorPhase 1Oct 1, 2013

Details

Founded: Berkeley, CA, US Jan 1, 2000
Last known activity: Jun 30, 2019